Flagship Pioneering Inc. - Net Worth and Insider Trading
Flagship Pioneering Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Flagship Pioneering Inc. owns 12 companies in total, including Foghorn Therapeutics Inc (FHTX) , Codiak BioSciences Inc (CDAKQ) , and Evelo Biosciences Inc (EVLO) among others .
Click here to see the complete history of Flagship Pioneering Inc.’s form 4 insider trades.
Insider Ownership Summary of Flagship Pioneering Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FHTX | Foghorn Therapeutics Inc | 2020-10-22 | 10 percent owner |
CDAKQ | Codiak BioSciences Inc | 2020-10-13 | 10 percent owner |
EVLO | Evelo Biosciences Inc | 2020-06-29 | 10 percent owner |
2019-06-18 | 10 percent owner | ||
2019-02-27 | 10 percent owner | ||
2018-12-07 | 10 percent owner | ||
2015-07-27 | 10 percent owner | ||
2013-09-18 | 10 percent owner | ||
2021-02-03 | 10 percent owner | ||
2020-12-03 | 10 percent owner | ||
2021-07-29 | director & 10 percent owner | ||
2022-10-13 | 10 percent owner |
Flagship Pioneering Inc. Trading Performance
Flagship Pioneering Inc. Ownership Network
Ownership Network List of Flagship Pioneering Inc.
Ownership Network Relation of Flagship Pioneering Inc.
Flagship Pioneering Inc. Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Flagship Pioneering Inc. is the 10 percent owner of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief Strategy/Bus Ops Officer Fanny Cavalie , Chief Medical Officer Alfonso Quintas Cardama , and Chief Medical Officer Samuel Agresta .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Flagship Pioneering Inc. made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 0 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,297 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,297 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Flagship Pioneering Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Flagship Pioneering Inc.. You might contact Flagship Pioneering Inc. via mailing address: 55 Cambridge Parkway, Suite 800e, Cambridge Ma 02142.